Member Exclusive Journal Content

Review: epigenetic agents in combined anticancer therapy

This review, brought to MedChemNet members by Future Medicinal Chemistry, highlights the use of combined application of epigenetic therapies to overcome problems with drug efficacy.


Please sign in or register for FREE

Register to RxNet

RxNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.


No comments yet.